Advanced Drug Delivery Systems Market

Global Advanced Drug Delivery Systems Market Size (2024 to 2029)

The advanced drug delivery systems market size was estimated at USD 265.1 Billion in 2024 and is projected to reach USD 361.2 Billion by the end of 2029, registering a CAGR of 6.8% during the forecast period.

Current Scenario of the Global Advanced Drug Delivery Systems Market

An advanced drug delivery system is an innovative technology that is designed to completely reduce the side effects of the treatment procedure by aiming to deliver the drug to specific targets. These systems will improve the efficacy of the treatment procedure by using various materials that overcome all the challenges faced due to the lack of bioavailability and the presence of toxic materials. The importance of the use of advanced drug delivery systems is incredibly increasing with the rising incidences of various cancer diseases like blood and breast cancer across the world. These systems can deliver promising results in curing diseases as the drug is delivered to the specified target tissue that cures the diseases at a higher rate. In this modern world, the need for the use of these unique systems can effectively cure many diseases, and the healthcare sector is greatly urged to adopt the necessary changes in delivering effective treatment procedures, especially in developed and emerging countries.

MARKET DRIVERS

In modern medicine, the demand for the use of advanced drug delivery systems is evolving in various aspects.

The number of people suffering from various chronic diseases is majorly showcasing the need for the use of advanced drug delivery systems. Advanced drug delivery systems are a great solution for evaluating proper treatment procedures, especially for targeted drug delivery. These systems can also make prominent use of the old drug molecules by modification of the healthcare system, which is well equipped with modern technology these days and is likely to elevate the growth rate of the advanced drug delivery systems market. People are more aware of accurate and effective treatment procedures, which is transforming the healthcare sector to eventually adopt the new technologies. In addition, ongoing research and development activities are needed to escalate the growth rate of the market. There are many research activities going on in countries like the US, India, China, Canada, and others, with growing support from the government through investments that are likely to enhance the growth rate of the market. The need to focus on delivering targeted therapeutical procedures using advanced technologies is highly needed in the healthcare industry so as to fulfill the demand of a growing number of patients suffering from chronic illnesses.

The prominence of offering innovative treatment procedures for patients suffering from HIV and other infectious diseases is subjected to escalate the growth rate of the market.

 HIV is becoming a serious concern in many countries where the total number of people getting infected with this disease is growing. According to the World Health Organization, there are more than 39.9 million people across the world suffering from HIV disease where 65% of them are from African regions in 2023. More than 1.3 million new HIV cases were registered in 2023 across the world, which is anticipating the need to enhance the proper drug delivery procedures in the coming years. The drug delivery systems play a crucial role in the people infected with HIV by managing the effective treatment procedure. Though there is no cure for HIV, the person under proper treatment procedure can lead a regular lifestyle with the proper diagnosis and care. World Health Organization. Global Fund and UNAIDS, along with WHO, are coping with different strategies to lower the risk of HIV disease. Their plan is to end the HIV epidemic by the end of 2030, which is aligned with the SDG target 3.3.

Increasing the need for personalized medicine through the launch of innovative and advanced treatment options to treat various diseases is creating huge growth opportunities for the market during the forecast period. Every patient is unique in their characteristics and responds differently to the treatment procedures. Therefore, there is a need to personalize medicine according to the patient’s characteristics, which will create the scope for a complete cure for any disease. Traditional drug delivery systems have many challenges, but advancements in the healthcare sector have rolled out new techniques to transform the best possibilities for curing chronic illnesses. This shall leverage the growth opportunities for the advanced drug delivery systems market during the forecast period.

MARKET RESTRAINTS

However, the cost of efficacy treatment procedures is very high, and the common people cannot afford them, slightly degrading the growth rate of the advanced drug delivery systems market. Lack of proper support from government authorities in undeveloped countries to promote quality and new treatment procedures additionally degrading the market’s growth. Also, stringent rules and regulations from higher authorities for the approval of newly developed therapeutic procedures or drugs can restrict the high growth rate of the advanced drug delivery systems market.  

High initial costs for R&D activities can solely impede the growth rate of the advanced drug delivery systems market.

It requires huge amounts of investment to develop a drug or any treatment procedure using advanced technologies. Lack of prominent support from the higher authorities and frequent product recalls can mostly degrade the growth rate of the advanced drug delivery systems market. Researchers also find it difficult to get the proper approvals from the government, which further limits the growth rate of the advanced drug delivery systems market.

REPORT COVERAGE

SEGMENTAL ANALYSIS

Global Advanced Drug Delivery Systems Market Analysis By Type of Delivery System

Oral drug delivery systems are leading with the dominant share of the advanced drug delivery systems market. The surging number of people suffering from gastrointestinal diseases is enhancing the growth rate of the oral drug delivery system’s segment. People suffering from gastrointestinal tract-related issues have trouble in the digestion of food and absorption of medicine, and oral drug delivery systems can resolve these issues. The injectable drug delivery segment is next in leading the largest share of the market. The injectable drug delivery system is taking a route in delivering the drug to specified areas like ears, knees, ears, and others. The inhalation drug delivery segment is expected to hit the highest CAGR by the end of the forecast period.

Global Advanced Drug Delivery Systems Market Analysis By Technology

The prodrug technology segment is likely to have a prominent share of the advanced drug delivery systems market. Prodrugs play an important role in creating an active drug, which levels up the drug’s lipoid nature when attached to the chemical moieties in the prodrugs. The controlled release technology segment is likely to have the highest growth opportunities throughout the forecast period. Controlled release technology is a kind of technique used to deliver the drug dosage form according to the requirement at the particular site of action cells. This technology is a highly comfortable and novel drug delivery method used to improve patient compliance. 

Global Advanced Drug Delivery Systems Market Analysis By Application

Oncology segment is gaining huge traction over the share of the advanced drug delivery systems market. Cancer is being one of the most common causes of death everywhere. The importance for the advanced drug delivery systems is increasing in unprecedented ways due to the quick adoption of various technological developments in the healthcare is ascribed in levelling up the growth rate of the market in the coming years.

REGIONAL ANALYSIS

North America's advanced drug delivery systems market is leading with the largest share of the market. High per capita income and the presence of the topmost pharmaceutical companies are majorly ascribed to leveraging the market’s growth rate for many years. Developed countries like the US and Canada strongly give preference to promoting high-quality treatment procedures by adopting new techniques in various fields. Artificial intelligence in the healthcare industry is creating wonders in different ways, and the complete adoption of these techniques in introducing the best suitable treatment procedures, especially for cancer and HIV diseases, can greatly fuel the market’s growth rate.

Europe is next to North America in gaining huge traction over the advanced drug delivery systems market size. High expenditure on healthcare and increasing prominence for regular checkups can dominantly fuel the growth rate of the advanced drug delivery systems market. The rising prevalence of chronic diseases & gastrointestinal issues due to changes in lifestyle habits is anticipated to level up the growth rate of the advanced drug delivery systems market. The growing knowledge over the popularity of entirely new medical treatment procedures that are proven to completely cure diseases is relatively to promote the growth rate of the market in the coming years in Europe.

Asia Pacific's advanced drug delivery systems market growth rate is accounted for as hitting the highest CAGR by the end of the forecast period. India and China are the most populous countries in the world. These emerging countries relatively seek high attention when launching new products with high support from government authorities. China is evolving with modern technologies, and the launch of new techniques to treat various diseases effectively is likely to gear up the growth rate of the market.

KEY PLAYERS IN THE GLOBAL ADVANCED DRUG DELIVERY SYSTEMS MARKET

Companies playing a prominent role in the global advanced drug delivery systems market profiled in this report are Pfizer, Boston Scientific Corporation, AbbVie, Baxter, Kindeva Drug Delivery, Teva Pharmaceutical Industries.,EliLilly and Company, Takeda Pharmaceutical Company Limited, Novartis, AstraZeneca

RECENT HAPPENINGS IN THE MARKET

In 2024, AbbVie and Neuroderm are anticipated to get approvals from the higher authorities for the treatment of Parkinson’s Disease using levodopa infusions. The companies also mentioned that innovations in drug delivery are rapidly changing, which is an important thing to making necessary changes in the treatment of Parkinson’s Disease in the Annual meeting of the American Academy of Neurology.

DETAILED SEGMENTATION OF GLOBAL ADVANCED DRUG DELIVERY SYSTEMS MARKET INCLUDED IN THIS REPORT

By Type of Delivery System

• Oral Drug Delivery

• Injectable Drug Delivery
• Inhalation Drug Delivery
• Transdermal Drug Delivery
• Transmucosal Drug Delivery

By Technology

• Prodrug Technology
• Controlled Release Technology
• Targeted Drug Delivery
• Nanotechnology

By Application

• Oncology
• Cardiovascular Disease
• Neurology
• Infectious Disease
• Other Applications

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa